|By Marketwired .||
|July 11, 2014 09:33 AM EDT||
FAIRFAX, VA--(Marketwired - July 11, 2014) - Members of the American Society for Radiation Oncology (ASTRO) have elected four new officers to serve on its Board of Directors and three members to serve on the Nominating Committee. The new officers will begin their terms at the Annual Business Meeting on Tuesday, September 16, 2014 at 11:30 a.m. Pacific time, at ASTRO's 56th Annual Meeting at Moscone Center in San Francisco.
The new Board of Directors members are:
David C. Beyer, MD, FASTRO, Arizona Oncology Services, Scottsdale, Arizona
Clinical Affairs and Quality Council Vice-chair
James A. Hayman, MD, MBA, University of Michigan, Ann Arbor, Michigan
Education Council Vice-chair
Stephen M. Hahn, MD, FASTRO, University of Pennsylvania, Philadelphia
Government Relations Council Vice-chair
Sameer R. Keole, MD, Mayo Clinic, Phoenix
"These four individuals bring an extensive amount of valuable experience and knowledge that will significantly impact our work on behalf of cancer patients worldwide," said Colleen A.F. Lawton, MD, FASTRO, chair of ASTRO's Board of Directors. "Their expertise in health policy, health services, quality, clinical research, education and government relations are integral elements to ensure ASTRO and radiation oncology continues to adapt to the changing health care environment."
Dr. Beyer is the medical director of Arizona Oncology Services in Scottsdale, Arizona. He is an active clinician with a primary focus on prostate cancer. He served ASTRO as a member of the Board of Directors (2007 to 2011) as the vice-chair and then the chair of the Health Policy Council; as co-chair of the Best Practices Committee and the Health Policy Committee; and as a member of the CPT/RUC Advisors Workgroup, the Clinical Affairs and Quality Committee and the Nominating Committee. He has represented ASTRO in front of Congress, the Centers for Medicare and Medicaid Services and the Government Accountability Office and to other medical societies and organizations.
Dr. Beyer has spent his entire career at Arizona Oncology Services, joining the practice in 1985. He specializes in prostate brachytherapy, including seed implants and high-dose-rate brachytherapy, as well as intensity modulated radiation therapy and image guided radiation therapy. He has helped develop and build new freestanding clinics and has participated in affiliations with several hospital-based clinics. Dr. Beyer is a member of the Editorial Board of the Journal of Brachytherapy, the official journal of the American Brachytherapy Society.
Dr. Beyer earned his medical degree in 1979 from the University of Arizona College of Medicine in Tucson, Arizona, completed his residency in internal medicine at the University of Arizona Health Sciences Center in 1982, and achieved his residency in radiation oncology at the University of California Los Angeles Center for Health Sciences in Los Angeles in 1985.
Dr. Hayman is a professor of radiation oncology and the associate chair for clinical activities at the University of Michigan in Ann Arbor, Michigan. His clinical interests include thoracic and breast cancers, and skin, ocular and central nervous system malignancies. Dr. Hayman is active in health services research and has served on various local and national committees related to quality of care. He served ASTRO as co-chair of the Practice Accreditation Workgroup; as chair of the Clinical Affairs and Quality Committee; as member and track chair (patient safety) of the Annual Meeting Scientific Committee; and as a member of both the Best of ASTRO Program Committee and the Research Evaluation Committee.
Dr. Hayman joined the University of Michigan in 1996, immediately following his residency. As a radiation oncologist active in health services research, he has been involved in quality of care-related projects with the National Quality Forum, the Cancer Quality Alliance, the National Comprehensive Cancer Network and the American Medical Association Physician Consortium for Performance Improvement. Dr. Hayman is helping to lead a state-wide collaborative quality initiative, the Michigan Radiation Oncology Quality Consortium, supported by Blue Cross/Blue Shield of Michigan.
Dr. Hayman concurrently earned his medical degree and his Master of Business Administration at the University of Chicago in 1991. He completed his residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School in Boston in 1996.
Dr. Hahn is the chair and Henry K. Pancoast Professor in the Department of Radiation Oncology at the University of Pennsylvania in Philadelphia. An active clinician, he is board certified in radiation oncology, medical oncology and internal medicine. Dr. Hahn's research interests include investigating the tumor microenvironment in a variety of human tumors including brain tumors; the molecular determinants of tumor microenvironment; and the evaluation of proton therapy as a way to improve the therapeutic impact of radiation therapy. He has served ASTRO as a member of the Annual Meeting Scientific Committee, the CME/MOC Committee and the Clinical Affairs and Quality Committee; as chair of the Task Force on Proton Beam Therapy; and as a member of the Radiation Oncology Institute's (ROI) Board of Trustees and a liaison for ROI's Research Committee.
Dr. Hahn began his career at the National Cancer Institute (NCI) in Bethesda, Maryland, in 1993. In 1995, he became a medical and radiation oncologist at Redwood Regional Oncology in Santa Rosa, California. He took the role of assistant professor of radiation oncology at the University of Pennsylvania in Philadelphia in 1996, where he currently practices. He has been a faculty member for eight years and is currently a course director of the Flims Course for Clinical Trials Methodology, an educational program that introduces junior clinical oncologists in any oncology subspecialty to the principles of good clinical trial design.
Dr. Hahn earned his medical degree from the Temple School of Medicine in Philadelphia in 1984, and completed his residency in internal medicine at the University of California, San Francisco in 1988, completed a fellowship in medical oncology at NCI in 1991 and achieved his residency in radiation oncology at NCI in 1994.
Dr. Keole is an assistant professor and senior associate consultant of radiation oncology at the Mayo Clinic in Scottsdale, Arizona. His clinical interests include proton therapy, pediatric oncology, central nervous system malignancies, lymphoma, sarcoma, and breast and genitourinary cancers. He served ASTRO as chair of the Government Relations Committee and the ASTRO Political Action Committee; as vice-chair of the Congressional Relations Subcommittee; and as a member of the CPT/RUC Advisors Workgroup, the Code Development and Valuation Subcommittee and the State Captain Initiative.
Dr. Keole began his medical career at the University of Florida in Gainesville, Florida, in 2005. In 2009, he joined Radiation Medicine Associates, a private practice group in Oklahoma City. He moved to the Mayo Clinic in 2012, where he leads the Proton Beam Therapy Program. He has served as a member of the Pediatric Proton Foundation's Board of Directors since 2009.
Dr. Keole earned his medical degree at the Ross University School of Medicine in Roseau, Dominica in 1999. He completed his radiation oncology residency at the Wayne State University School of Medicine in Detroit in 2004.
ASTRO's Nominating Committee is responsible for preparing a slate of nominees for each elective position of ASTRO to be filled that year. The committee consists of 12 members: the immediate past chair of the Board of Directors, the five Council chairs and six elected members that are not currently serving on ASTRO's Board of Directors. The six elected members serve staggered three-year terms. Three elected positions on the Nominating Committee were filled by election this year.
The new Nominating Committee members are:
Nominating Committee Academic Physician
William M. Mendenhall, MD, University of Florida, Gainesville, Florida
Nominating Committee Community Practice Physician
Patricia Hardenbergh, MD, Shaw Regional Cancer Center, Edwards, Colorado
Nominating Committee Radiobiologist
Kathryn Held, PhD, Massachusetts General Hospital, Boston
For more information about ASTRO's 56th Annual Meeting, visit www.astro.org/AnnualMeeting.
For press registration and media policies for ASTRO's 56th Annual Meeting, visit www.astro.org/AMpress.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology • Biology • Physics (www.redjournal.org) and Practical Radiation Oncology (www.practicalradonc.org); developed and maintains an extensive patient website, www.rtanswers.org; and created the Radiation Oncology Institute (www.roinstitute.org), a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org.
The following files are available for download:
Intelligent machines are here. Robots, self-driving cars, drones, bots and many IoT devices are becoming smarter with Machine Learning. In her session at @ThingsExpo, Sudha Jamthe, CEO of IoTDisruptions.com, will discuss the next wave of business disruption at the junction of IoT and AI, impacting many industries and set to change our lives, work and world as we know it.
Oct. 27, 2016 11:00 AM EDT Reads: 148
With an estimated 50 billion devices connected to the Internet by 2020, several industries will begin to expand their capabilities for retaining end point data at the edge to better utilize the range of data types and sheer volume of M2M data generated by the Internet of Things. In his session at @ThingsExpo, Don DeLoach, CEO and President of Infobright, discussed the infrastructures businesses will need to implement to handle this explosion of data by providing specific use cases for filterin...
Oct. 27, 2016 11:00 AM EDT Reads: 3,046
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.
Oct. 27, 2016 11:00 AM EDT Reads: 2,083
In past @ThingsExpo presentations, Joseph di Paolantonio has explored how various Internet of Things (IoT) and data management and analytics (DMA) solution spaces will come together as sensor analytics ecosystems. This year, in his session at @ThingsExpo, Joseph di Paolantonio from DataArchon, will be adding the numerous Transportation areas, from autonomous vehicles to “Uber for containers.” While IoT data in any one area of Transportation will have a huge impact in that area, combining sensor...
Oct. 27, 2016 11:00 AM EDT Reads: 1,136
DevOps is speeding towards the IT world like a freight train and the hype around it is deafening. There is no reason to be afraid of this change as it is the natural reaction to the agile movement that revolutionized development just a few years ago. By definition, DevOps is the natural alignment of IT performance to business profitability. The relevance of this has yet to be quantified but it has been suggested that the route to the CEO’s chair will come from the IT leaders that successfully ma...
Oct. 27, 2016 10:30 AM EDT Reads: 16,634
In his session at Cloud Expo, Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, will provide economic scenarios that describe how the rapid adoption of software-defined everything including cloud services, SDDC and open networking will change GDP, industry growth, productivity and jobs. This session will also include a drill down for several industries such as finance, social media, cloud service providers and pharmaceuticals.
Oct. 27, 2016 10:30 AM EDT Reads: 2,075
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
Oct. 27, 2016 10:15 AM EDT Reads: 1,397
We are always online. We access our data, our finances, work, and various services on the Internet. But we live in a congested world of information in which the roads were built two decades ago. The quest for better, faster Internet routing has been around for a decade, but nobody solved this problem. We’ve seen band aid approaches like CDNs that attack a niche's slice of static content part of the Internet, but that’s it. It does not address the dynamic services-based Internet of today. It doe...
Oct. 27, 2016 10:15 AM EDT Reads: 2,029
Ask someone to architect an Internet of Things (IoT) solution and you are guaranteed to see a reference to the cloud. This would lead you to believe that IoT requires the cloud to exist. However, there are many IoT use cases where the cloud is not feasible or desirable. In his session at @ThingsExpo, Dave McCarthy, Director of Products at Bsquare Corporation, will discuss the strategies that exist to extend intelligence directly to IoT devices and sensors, freeing them from the constraints of ...
Oct. 27, 2016 10:15 AM EDT Reads: 3,205
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
Oct. 27, 2016 09:15 AM EDT Reads: 2,156
By now most people have either created their configuration management solution or are just embarking on this journey. In his session at @DevOpsSummit at 19th Cloud Expo, Marco Ceppi, a DevOps Engineer working at Canonical, will discuss how to take configuration management to the next level with modelling and orchestration. He will also discuss how and why people are moving from a machine-centric view to a service/application-oriented view of deployments, and how you can leverage the knowledge a...
Oct. 27, 2016 09:00 AM EDT Reads: 2,048
@ThingsExpo has been named the Top 5 Most Influential M2M Brand by Onalytica in the ‘Machine to Machine: Top 100 Influencers and Brands.' Onalytica analyzed the online debate on M2M by looking at over 85,000 tweets to provide the most influential individuals and brands that drive the discussion. According to Onalytica the "analysis showed a very engaged community with a lot of interactive tweets. The M2M discussion seems to be more fragmented and driven by some of the major brands present in the...
Oct. 27, 2016 08:45 AM EDT Reads: 11,585
In the 21st century, security on the Internet has become one of the most important issues. We hear more and more about cyber-attacks on the websites of large corporations, banks and even small businesses. When online we’re concerned not only for our own safety but also our privacy. We have to know that hackers usually start their preparation by investigating the private information of admins – the habits, interests, visited websites and so on. On the other hand, our own security is in danger bec...
Oct. 27, 2016 08:15 AM EDT Reads: 525
Enterprises have been using both Big Data and virtualization for years. Until recently, however, most enterprises have not combined the two. Big Data's demands for higher levels of performance, the ability to control quality-of-service (QoS), and the ability to adhere to SLAs have kept it on bare metal, apart from the modern data center cloud. With recent technology innovations, we've seen the advantages of bare metal erode to such a degree that the enhanced flexibility and reduced costs that cl...
Oct. 27, 2016 07:45 AM EDT Reads: 523
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, wil...
Oct. 27, 2016 07:30 AM EDT Reads: 1,952